Helgi Sigmundsson
Gastroenterology · Huntington, WVNPI 1023441375
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,144 and has fallen 96.5% since, to $40 in 2024.
Across 207 payments — averaging $12.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$547
- Johnson & Johnson$420
- AbbVie$287
- Novo Nordisk$246
- Takeda Pharmaceuticals U.S.A., Inc.$189
- Gilead$132
- plus $851 from 28 others
What the payments were for
- Food & beverage$2,672100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 56 | $547 |
| Johnson & Johnson(2 entities) | 39 | $420 |
| AbbVie(2 entities) | 17 | $287 |
| Novo Nordisk | 16 | $246 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $189 |
| Gilead | 9 | $132 |
| Intercept Pharmaceuticals, Inc. | 4 | $72 |
| Pfizer | 4 | $56 |
| Biohaven Pharmaceuticals, Inc. | 4 | $54 |
| Ironwood Pharmaceuticals, Inc | 4 | $53 |
| Bristol Myers Squibb | 3 | $52 |
| Braintree Laboratories, Inc. | 4 | $50 |
| Boehringer Ingelheim | 3 | $44 |
| UCB, Inc. | 2 | $41 |
| Shionogi Inc | 2 | $35 |
| Lilly USA, LLC | 1 | $34 |
| Redhill Biopharma Inc. | 2 | $31 |
| Avanir Pharmaceuticals, Inc. | 2 | $29 |
| Amgen | 2 | $28 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Merck | 2 | $28 |
| Vifor Pharma, Inc. | 2 | $26 |
| AstraZeneca | 2 | $25 |
| Amarin Pharma, Inc. | 1 | $20 |
| Smith+Nephew | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Genentech USA, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Concordia Pharmaceuticals Inc. | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$2,672 in reported general payments places this provider in the 60th percentile of 72 gastroenterology providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 15 | $176 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Huntington
- Wesam FrandahHuntington$28K
- Ahmed SherifHuntington$10K
- Matthew RohrbachHuntington$7K
- John EastoneHuntington$7K
- Charles HuhHuntington$7K
- Umapathy SundaramHuntington$5K
- Maen KamalHuntington$3K
- Pramod PantangiHuntington$3K
- Larry CarterHuntington$2K
- Adnan ElghezewiHuntington$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.